153 related articles for article (PubMed ID: 10705242)
1. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Shamma A; Doki Y; Tsujinaka T; Shiozaki H; Inoue M; Yano M; Kawanishi K; Monden M
Oncology; 2000 Feb; 58(2):152-8. PubMed ID: 10705242
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma.
Ohashi Y; Sasano H; Yamaki H; Shizawa S; Shineha R; Akaishi T; Satomi S; Nagura H
Anticancer Res; 1999; 19(3A):1843-8. PubMed ID: 10470125
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.
Itami A; Shimada Y; Watanabe G; Imamura M
Oncology; 1999 Nov; 57(4):311-7. PubMed ID: 10575318
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
7. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis.
Takata T; Kudo Y; Zhao M; Ogawa I; Miyauchi M; Sato S; Cheng J; Nikai H
Cancer; 1999 Sep; 86(6):928-35. PubMed ID: 10491517
[TBL] [Abstract][Full Text] [Related]
9. Significance of the expression of p27Kip1 in esophageal squamous cell carcinomas.
Kagawa Y; Yoshida K; Hirai T; Toge T
Dis Esophagus; 2000; 13(3):179-84. PubMed ID: 11206629
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma.
Feakins RM; Mulcahy HE; Quaglia A; Jawhari A; Zhang Z; Patchett SE
Cancer; 2000 Oct; 89(8):1684-91. PubMed ID: 11042561
[TBL] [Abstract][Full Text] [Related]
12. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.
Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y
Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of p27(kip1), p16 and proliferating cell nuclear antigen in nasopharyngeal carcinoma].
Li L; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):347-9. PubMed ID: 14514381
[TBL] [Abstract][Full Text] [Related]
16. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus.
Shibata H; Matsubara O; Wakiyama H; Tanaka S
Pathol Res Pract; 2001; 197(3):157-64. PubMed ID: 11314778
[TBL] [Abstract][Full Text] [Related]
17. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
18. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H
Oncology; 2003; 65(4):355-62. PubMed ID: 14707456
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
